EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease

Prapawadee Pirintr, Vudhiporn Limprasutr, Anudep Rungsipipat, Kasem Rattanapinyopituk, Suwanakiet Sawangkoon, Nakkawee Saengklub, Anusak Kijtawornrat iD

Veterinary Medicine and Science · 2026

DOI: 10.1002/vms3.70695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Medicine and Science, 2026. Verfasst von Prapawadee Pirintr und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Ivabradine, Dog Diseases, Apoptosis, Cardiovascular Agents. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program, Special Task Force for Activating Research, Specific League Funds from Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ivabradine, a specific funny channel blocker, has shown cardiovascular benefits in humans and animals. However, its effects on haemodynamics, cardiac function, ventricular remodelling and cardiac apoptosis in asymptomatic dogs with myxomatous mitral valve disease (MMVD) stage B2 remain unclear.

Objective

To investigate the effect of long‐term oral ivabradine on heart rate (HR), haemodynamics, cardiac function and apoptosis in dogs with MMVD stage B2.

Methods

Four dogs with MMVD stage B2 received ivabradine (1 mg/kg orally, q12h) for 3 months. Under general anaesthesia (propofol and isoflurane), electrocardiograms and invasive measurements of left ventricular, aortic, pulmonic, right atrial and pulmonary capillary wedge pressures were obtained at baseline and 3 months. Endomyocardial biopsies were collected at both timepoints for histopathology and immunohistochemical evaluation of Bcl‐2 and Bax expression to assess apoptosis.

Results

Ivabradine decreased HR by 30.4% ( p < 0.05) without significantly affecting systemic or pulmonary pressures, vascular resistance or systolic/diastolic function. Histopathological analysis showed significant reductions in myocyte vacuolization (68.5%), glycogen accumulation (47.6%), interstitial fibrosis (57.3%) and fibrofatty infiltration (77.8%) ( p < 0.05). The apoptosis index was reduced by 17.0% ( p < 0.05), and Bcl‐2 expression tended to increase ( p = 0.06).

Conclusion

Chronic ivabradine treatment lowered HR and reduced cardiac structural remodelling and apoptosis without impairing cardiac function in dogs with MMVD stage B2. These findings support the potential of ivabradine as a therapeutic option for asymptomatic canine heart disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IvabradineDog DiseasesApoptosisCardiovascular AgentsCell DeathAnimalsDogsFemaleMaleHeart RateHemodynamics

Stichwörter der Autor:innen

apoptosiscardiac functionhaemodynamicsheart rateivabradinemyxomatous mitral valve diseaseremodelling

Substanzen

IvabradineCardiovascular Agents

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
  • Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
  • Center of Excellence for Companion Animal Cancer (CE-CAC) Department of Pathology, Faculty of Veterinary Science Chulalongkorn University, Bangkok, Thailand.
  • Department of Physiology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  • Research Clusters: Research Study and Testing of Drug's Effect Related to Cardiovascular System in Laboratory Animal, Chulalongkorn University, Bangkok, Thailand.

ORCID-Profile: Anusak Kijtawornrat

Förderung

  • the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program
  • Special Task Force for Activating Research
  • Specific League Funds from Mahidol University

Zitieren

APA

Pirintr, P., Limprasutr, V., Rungsipipat, A., Rattanapinyopituk, K., Sawangkoon, S., Saengklub, N., & Kijtawornrat, A. (2026). Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.70695

Vancouver

Pirintr P, Limprasutr V, Rungsipipat A, Rattanapinyopituk K, Sawangkoon S, Saengklub N, et al. Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease. Veterinary Medicine and Science. 2026. doi:10.1002/vms3.70695

BibTeX
@article{Pirintr2026,
  author = {Pirintr, Prapawadee and Limprasutr, Vudhiporn and Rungsipipat, Anudep and Rattanapinyopituk, Kasem and Sawangkoon, Suwanakiet and Saengklub, Nakkawee and Kijtawornrat, Anusak},
  title = {Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease},
  journal = {Veterinary Medicine and Science},
  year = {2026},
  doi = {10.1002/vms3.70695}
}
Kostenlos starten →